טאזוצין 2.25 גרם

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

PIPERACILLIN AS SODIUM 2 G/VIAL; TAZOBACTAM SODIUM 0.25 G/VIAL

Disponível em:

NEOPHARM LTD

Código ATC:

J01CR05

Forma farmacêutica:

POWDER FOR SOLUTION FOR INJECTION

Via de administração:

I.V

Fabricado por:

WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.

Grupo terapêutico:

PIPERACILLIN AND ENZYME INHIBITOR

Indicações terapêuticas:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Data de autorização:

2010-06-01